Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Hepatitis b e antigen negative"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Puigvehí, T. Broquetas, José A. Carrión, Juan Jose Hernandez, Nuria Cañete, L. Canillas, Susana Coll, Ana Viu, Montserrat García-Retortillo, Xavier Bessa, Miquel Micó
Publikováno v:
World Journal of Hepatology
Background: Hepatitis B e antigen-negative chronic hepatitis B patients under nucleos(t)ids analogues (NAs) rarely achieve hepatitis B surface antigen (HBsAg) loss. Aim: To evaluate if the addition of pegylated interferon (Peg-IFN) could decrease HBs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f3d9a9852cb66d859231bb502cd18b
http://europepmc.org/articles/PMC7701972
http://europepmc.org/articles/PMC7701972
Autor:
Koji Yamashita, Mayu Higuchi, Yuka Takahashi, Sakura Kirino, Nobuyuki Enomoto, Kenta Takaura, Namiki Izumi, Mao Okada, Masayuki Kurosaki, Jun Itakura, Nobuharu Tamaki, Hiroyuki Nakanishi, Wan Wang, Yutaka Yasui, Leona Osawa, Kaoru Tsuchiya, Shun Kaneko, Chiaki Maeyashiki, Shuhei Sekiguchi, Yuka Hayakawa
Publikováno v:
JGH Open, Vol 4, Iss 3, Pp 429-432 (2020)
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim Loss of hepatitis B surface antigen (HBsAg) is an important goal in the treatment of chronic hepatitis B. We investigated whether switching from long‐term entecavir (ETV) administration to tenofovir (TFV) (tenofovir alafenamide [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab4871ab528dc126bbc48f133209431
https://doaj.org/article/07f5cac2e4b041099bd76c677205797c
https://doaj.org/article/07f5cac2e4b041099bd76c677205797c
Autor:
Monika Mani, Gopalsamy Sarangan, Ramya Barani, Shanthi Vijayaraghavan, Priya Abraham, Padma Srikanth
Publikováno v:
Indian Journal of Medical Microbiology, Vol 37, Iss 3, Pp 387-392 (2019)
Introduction: Hepatitis B virus (HBV) is the most common aetiological factor causing hepatocellular carcinoma (HCC). HBx gene plays an enigmatic role in HBV-related HCC. In this study we have analysed amino acid substitutions in HBx from HBV-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d052ef09cdf5d627ae64fe0286b0b45
http://www.ijmm.org/article.asp?issn=0255-0857
http://www.ijmm.org/article.asp?issn=0255-0857
Autor:
Mehmet Bayram, Engin Altinkaya, Serkan Yaraş, Ali Riza Koksal, Canan Alkim, Banu Yılmaz Özgüven, Osman Özdoğan
Publikováno v:
Viral Hepatitis Journal, Vol 24, Iss 3, Pp 79-84 (2018)
WOS: 000454450900005
Objectives: Most of the patients with hepatitis B e (HBe)-negative hepatitis B have persistently normal transaminases (PNALT) levels. Patients, who have higher fibrosis and necroinflammatory activity scores, are at high risk
Objectives: Most of the patients with hepatitis B e (HBe)-negative hepatitis B have persistently normal transaminases (PNALT) levels. Patients, who have higher fibrosis and necroinflammatory activity scores, are at high risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248f24fcf0ed5edea8fe94deb1497bdf
https://doi.org/10.4274/vhd.2018.0010
https://doi.org/10.4274/vhd.2018.0010
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(8)
This study investigated the ability of hepatitis B core-related antigen (HBcrAg) to predict hepatitis B virus (HBV) relapse in HBeAg-negative patients after cessation of entecavir therapy. A total of 301 HBeAg-negative patients without cirrhosis who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f049f9ce22e5a79d06cc86f61bed0f
https://pubmed.ncbi.nlm.nih.gov/33932245
https://pubmed.ncbi.nlm.nih.gov/33932245
Autor:
Ulku User, Figen Sarigul
Publikováno v:
Mediterranean Journal of Infection Microbes and Antimicrobials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7307ec793f0cae33ead3f8a92fee261
https://doi.org/10.4274/mjima.galenos.2020.2020.14
https://doi.org/10.4274/mjima.galenos.2020.2020.14
Autor:
Hong Zhao, Jianhua Hu, Xuan Zhang, Tuxiang Chen, Meifang Yang, Jie Zheng, Zhiping Chen, Lanjuan Li, Yong Wang, Gongying Jiang
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
The Journal of International Medical Research
The Journal of International Medical Research
Objective Liver inflammatory activity staging is critical to guide the treatment of chronic hepatitis B virus (CHB) infection. Here, we aimed to identify practical clinical biomarkers of moderate inflammatory activity in hepatitis B e-antigen (HBeAg)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063d64368bae83992b240ff0eb1e5956
https://doaj.org/article/919b334c295f48ce923740965cc6b77c
https://doaj.org/article/919b334c295f48ce923740965cc6b77c
Autor:
Arm Saifuddin Ekram, MH Rashid, Md. Abdul Alim, Mmr Khan, Mmh Chowdhury, M Obaidullah Ibne Ali, MK Rahman, DK Mohanta, K Khanam
Publikováno v:
TAJ: Journal of Teachers Association. 25:90-96
not availableTAJ 2012; 25: 90-96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53206c94891473554ab0fdc96cae3420
https://doi.org/10.3329/taj.v25i0.37567
https://doi.org/10.3329/taj.v25i0.37567
Autor:
Maurizia Rossana Brunetto, A. Caputo, Pietro Lampertico, Diethelm Messinger, Jörg Petersen, Georgios Bakalos, T Asselah, Markus Cornberg, George V. Papatheodoridis, Rothe, Patrick T F Kennedy, Pavlovic
Publikováno v:
Annals of Gastroenterology
Background Peginterferon alfa-2a induces durable responses in some hepatitis B e antigen-negative patients, but robust pretreatment predictors are not available to identify likely responders. In this study we aimed to develop genotype-specific baseli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8074aa0fca814e5ccfa300e89e499f2
http://europepmc.org/articles/PMC6191871
http://europepmc.org/articles/PMC6191871